Literature DB >> 24979554

Fluids in ARDS: from onset through recovery.

Luciano Gattinoni1, Massimo Cressoni, Luca Brazzi.   

Abstract

PURPOSE OF REVIEW: Early acute respiratory distress syndrome (ARDS) is characterized by protein-rich inflammatory lung edema often associated with a hydrostatic component. Mechanical ventilation with positive intrathoracic pressure further induces salt and water retention, while impairing the pathways designed for edema clearance. In this framework, we will review the recent findings on fluid strategy and edema clearance in ARDS. RECENT
FINDINGS: Consistently, conservative strategies lead to better oxygenation and reduce the length of mechanical ventilation. A possible drawback associated with conservative strategy is the impaired cognitive function. Echography may be used for safer use of furosemide or hemofiltration therapy during edema clearance. Albumin and furosemide techniques may accelerate edema clearance, particularly when pulmonary capillary permeability is restored. Beta-2 agonist therapy does not accelerate edema clearance and is potentially dangerous.
SUMMARY: Lung edema is likely the single pathogenic factor more relevant for ARDS severity and outcome. Fluid overload must be avoided. Several monitoring techniques are available to reach this target. No specific studies are available to recommend a given fluid composition in ARDS. In our opinion, the general recommendations for fluid composition suggested for severe sepsis and septic shock should be applied to ARDS that may be considered an organ-confined sepsis.

Entities:  

Mesh:

Year:  2014        PMID: 24979554     DOI: 10.1097/MCC.0000000000000105

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  10 in total

Review 1.  Acute respiratory distress syndrome in traumatic brain injury: how do we manage it?

Authors:  Valentina Della Torre; Rafael Badenes; Francesco Corradi; Fabrizio Racca; Andrea Lavinio; Basil Matta; Federico Bilotta; Chiara Robba
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

2.  Shock Management for Cardio-surgical Intensive Care Unit Patient: The Silver Days.

Authors:  Till Hauffe; Bernard Krüger; Dominique Bettex; Alain Rudiger
Journal:  Card Fail Rev       Date:  2016-05

3.  Risk factors for outcomes of acute respiratory distress syndrome patients: a retrospective study.

Authors:  Qingqing Dai; Sicong Wang; Ruijin Liu; Hongliang Wang; Junbo Zheng; Kaijiang Yu
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

4.  Restrictive Fluid Resuscitation Leads to Better Oxygenation than Non-Restrictive Fluid Resuscitation in Piglets with Pulmonary or Extrapulmonary Acute Respiratory Distress Syndrome.

Authors:  Shunan Ye; Qiujie Li; Shiying Yuan; Huaqing Shu; Yin Yuan
Journal:  Med Sci Monit       Date:  2015-07-12

Review 5.  Choice of fluids in critically ill patients.

Authors:  Claude Martin; Andrea Cortegiani; Cesare Gregoretti; Ignacio Martin-Loeches; Carole Ichai; Marc Leone; Gernot Marx; Sharon Einav
Journal:  BMC Anesthesiol       Date:  2018-12-22       Impact factor: 2.217

Review 6.  Perioperative anaesthetic management of patients with or at risk of acute distress respiratory syndrome undergoing emergency surgery.

Authors:  Denise Battaglini; Chiara Robba; Patricia Rieken Macêdo Rocco; Marcelo Gama De Abreu; Paolo Pelosi; Lorenzo Ball
Journal:  BMC Anesthesiol       Date:  2019-08-14       Impact factor: 2.217

Review 7.  Scandinavian clinical practice guideline on fluid and drug therapy in adults with acute respiratory distress syndrome.

Authors:  J Claesson; M Freundlich; I Gunnarsson; J H Laake; M H Møller; P O Vandvik; T Varpula; T A Aasmundstad
Journal:  Acta Anaesthesiol Scand       Date:  2016-03-14       Impact factor: 2.105

8.  Potential role for furosemide in the treatment of acute respiratory distress syndrome (ARDS) and an unusual presentation of pulmonary embolism in a complex patient.

Authors:  Lior Zornitzki; Gil Bornstein
Journal:  BMJ Case Rep       Date:  2020-08-24

Review 9.  Metabolomics and Its Application to Acute Lung Diseases.

Authors:  Kathleen A Stringer; Ryan T McKay; Alla Karnovsky; Bernadette Quémerais; Paige Lacy
Journal:  Front Immunol       Date:  2016-02-29       Impact factor: 7.561

10.  Orally delivered resveratrol-loaded lipid-core nanocapsules ameliorate LPS-induced acute lung injury via the ERK and PI3K/Akt pathways.

Authors:  Maria Talita Pacheco de Oliveira; Diego de Sá Coutinho; Éverton Tenório de Souza; Sílvia Stanisçuaski Guterres; Adriana Raffin Pohlmann; Patricia Machado Rodrigues Silva; Marco Aurélio Martins; Andressa Bernardi
Journal:  Int J Nanomedicine       Date:  2019-07-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.